The cerebrospinal fluid proteome in HIV infection: change associated with disease severity
Authors:
- Thomas E AngelTAThomas E Angel
- Jon M JacobsJJJon M Jacobs
- Serena S SpudichSSSerena S Spudich
- Marina A GritsenkoMGMarina A Gritsenko
- Dietmar FuchsDFDietmar Fuchs
- Teri LieglerTLTeri Liegler
- Henrik ZetterbergHZHenrik Zetterberg
- David G CampIIDCDavid G CampII
- Richard W PriceRPRichard W Price
- Richard D SmithRSRichard D Smith
Open Access
- 20 March 2012
- journal article
- research article
- Published by Springer Nature in Clinical Proteomics
- Vol. 9 (1) , 3
Abstract
Background: Central nervous system (CNS) infection is a nearly universal feature of untreated systemic HIV infection with a clinical spectrum that ranges from chronic asymptomatic infection to severe cognitive and motor dysfunction. Analysis of cerebrospinal fluid (CSF) has played an important part in defining the character of this evolving infection and response to treatment. To further characterize CNS HIV infection and its effects, we applied advanced high-throughput proteomic methods to CSF to identify novel proteins and their changes with disease progression and treatment.Results: After establishing anaccurate mass and time(AMT) tag database containing 23,141 AMT tags for CSF peptides, we analyzed 91 CSF samples by LC-MS from 12 HIV-uninfected and 14 HIV-infected subjects studied in the context of initiation of antiretroviral therapy and correlated abundances of identified proteins a) within and between subjects, b) with all other proteins across the entire sample set, and c) with "external" CSF biomarkers of infection (HIV RNA), immune activation (neopterin) and neural injury (neurofilament light chain protein, NFL). We identified a mean of 2,333 +/- 328 (SD) peptides covering 307 +/-16 proteins in the 91 CSF sample set. Protein abundances differed both between and within subjects sampled at different time points and readily separated those with and without HIV infection. Proteins also showed inter-correlations across the sample set that were associated with biologically relevant dynamic processes. One-hundred and fifty proteins showed correlations with the external biomarkers. For example, using a threshold of cross correlation coefficient (Pearson's) ≤ -0.3 and ≥0.3 for potentially meaningful relationships, a total of 99 proteins correlated with CSF neopterin (43 negative and 56 positive correlations) and related principally to neuronal plasticity and survival and to innate immunity. Pathway analysis defined several networks connecting the identified proteins, including one with amyloid precursor protein as a central node.Conclusions: Advanced CSF proteomic analysis enabled the identification of an array of novel protein changes across the spectrum of CNS HIV infection and disease. This initial analysis clearly demonstrated the value of contemporary state-of-the-art proteomic CSF analysis as a discovery tool in HIV infection with likely similar application to other neurological inflammatory and degenerative diseases.Keywords
This publication has 95 references indexed in Scilit:
- Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumabAnnals of Neurology, 2010
- Light subunit of neurofilament triplet protein in the cerebrospinal fluid after subthalamic nucleus stimulation for Parkinson’s diseaseActa Neurologica Scandinavica, 2010
- Identification of Glycoproteins in Human Cerebrospinal Fluid2009
- Cerebrospinal fluid markers in central nervous system HIV infection and AIDS dementia complex2007
- Cerebrospinal Fluid HIV-1 Infection Usually Responds Well to Antiretroviral TreatmentAntiviral Therapy, 2005
- Genetic Composition of Human Immunodeficiency Virus Type 1 in Cerebrospinal Fluid and Blood without Treatment and during Failing Antiretroviral TherapyJournal of Virology, 2005
- The neuropathogenesis of AIDSNature Reviews Immunology, 2005
- Discordant Human Immunodeficiency Virus Type 1 Drug Resistance Mutations, Including K103N, Observed in Cerebrospinal Fluid and PlasmaClinical Infectious Diseases, 2002
- Early viral brain invasion in iatrogenic human immunodeficiency virus infectionNeurology, 1992
- Microglia in the giant cell encephalitis of acquired immune deficiency syndrome: proliferation, infection and fusionActa Neuropathologica, 1988